+ -Text Size

Peer Review Committee for Tumor Biology and Genomics (TBG)

Areas reviewed: In vivo tumor models, oncogenes and tumor suppressor genes in vivo, gene target validation, drug efficacy testing, human genetics/genomics, pharmacogenetics, pharmacogenomics, genetic risk, genotype to phenotype, gene therapy testing, and biomarker identification/development

Sheri L. Holmen, PhD, Chair
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Scott Oakes, MD, PhD, Vice Chair 
University of California, San Francisco, CA

Thomas Barber, PhD
Lilly Research Laboratories, Indianapolis, IN

Jonathan R. Brody, PhD
Thomas Jefferson University, Philadelphia, PA

Ramana Davuluri, PhD
Wistar Institue, Philadelphia, PA

Nancy Gargano, Stakeholder
Stevensville, MI 

Scott A. Gerber, PhD
Geisel School of Medicine, Lebanon, NH

Steven R. Grossman, MD, PhD
Virginia Commonwealth University, Richmond, VA

Yibin Kang, PhD
Princeton University, Princeton, NJ

Ruth O'Regan, MD
Emory University, Atlanta, GA

W. Kimryn Rathmell, MD, PhD
University of North Carolina, Chapel Hill, NC

Marilyn Rex, Stakeholder
San Mateo, CA

Ralph Scully, MB, BS, PhD
Beth Israel Deaconess Medical Center, Boston, MA

Amanda E. Toland, PhD
Ohio State University, Columbus, OH